Tag: nasdaq:crvs

December 8, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Atreca Climbs 45 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
July 7, 2019

5 Top Weekly NASDAQ Biotech & Pharma Stocks: Corvus Soars

Which companies were on the rise last week? We take a look at the top five biotech and pharma stocks...
February 6, 2019

Corvus Presents Updated Biomarker and Clinical Results from Lead Pipeline Programs

Corvus Pharmaceuticals (NASDAQ:CRVS) has announced its updated biomarker and clinical results from its two lead programs, CPI-444 and CPI-006. As...
January 11, 2019

Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas

Corvus Pharmaceuticals (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies, announced data...